TRAF6 and cancer: EGCG’s binding to tumor necrosis factor receptor-associated factor TRAF6, especially to specific amino acids like Gln54, Asp57, and Ile72, significantly attenuates TRAF6’s E3 ubiquitin ligase activity, contributing to cancer prevention [72].